首页> 外文期刊>Molecular Therapy - Methods & Clinical Development >Generate TALE/TALEN as Easily and Rapidly as Generating CRISPR
【24h】

Generate TALE/TALEN as Easily and Rapidly as Generating CRISPR

机译:像产生CRISPR一样轻松迅速地生成故事/塔伦

获取原文
       

摘要

TALE has always had potential as a gene-editing and regulatory tool. However, with the advent of CRISPR/Cas9, an easier to use tool with the same function, TALE has recently been abandoned because of the time-consuming and low-efficiency process required for its construction. The off-target activity of CRISPR/Cas9 has been a challenge to its in?vivo application. By contrast, TALE has been applied in?vivo for gene editing and therapy because of its high targeting capability. To overcome the key limitation of the TALE technique, we developed a high-efficiency method for constructing custom TALEs. We created 62 new monomers and developed a new pipeline that enabled assembly of custom TALEs in just 1?day. We verified the new method by assembling nine TALEs targeting the promoters of two transcription factor genes: HNF4α and E47. The expression of the two endogenous genes in two cancer cells, HepG2 and PANC1, was activated by the constructed TALEs, which promoted differentiation of the two cancer cells. Using the new method, custom TALEs can be generated as easily and rapidly as CRISPR, thus promoting the wide application of TALE-based techniques.
机译:故事始终具有作为基因编辑和监管工具的潜力。然而,随着CRISPR / CAS9的出现,由于其施工所需的耗时和低效工艺,最近被遗弃了更容易使用具有相同功能的工具。 CRISPR / CAS9的偏离目标活动对其体内申请感到挑战。相比之下,由于其高靶向能力,故事已被应用于基因编辑和治疗的体内。为了克服故事技术的关键限制,我们开发了一种构建定制故事的高效方法。我们创建了62个新单体,并开发了一种新的管道,使能在1?日仅启用定制故事。我们通过组装靶向两个转录因子基因的启动子的九个故事来验证新方法:HNF4α和E47。由构造的故事激活两种癌细胞,HepG2和Panc1中的两个内源基因的表达,其促进了两种癌细胞的分化。使用新方法,可以轻松且快速地生成定制故事作为CRISPR,从而促进基于故事的技术的广泛应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号